These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20113217

  • 1. Anti-chemokine small molecule drugs: a promising future?
    Proudfoot AE, Power CA, Schwarz MK.
    Expert Opin Investig Drugs; 2010 Mar; 19(3):345-55. PubMed ID: 20113217
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM, Santos-Costa Q.
    Acta Med Port; 2008 Dec; 21(5):497-504. PubMed ID: 19187693
    [Abstract] [Full Text] [Related]

  • 4. Chemokine receptors: attractive targets for drug discovery.
    Godessart N.
    Ann N Y Acad Sci; 2005 Jun; 1051():647-57. PubMed ID: 16127005
    [Abstract] [Full Text] [Related]

  • 5. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies.
    Dhami H, Fritz CE, Gankin B, Pak SH, Yi W, Seya MJ, Raffa RB, Nagar S.
    J Clin Pharm Ther; 2009 Apr; 34(2):147-60. PubMed ID: 19250135
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
    Suresh P, Wanchu A.
    J Postgrad Med; 2006 Apr; 52(3):210-7. PubMed ID: 16855325
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CCR5 antagonists: a new tool in fighting HIV.
    Jülg B, Goebel FD.
    J HIV Ther; 2005 Dec; 10(4):68-71. PubMed ID: 16519245
    [Abstract] [Full Text] [Related]

  • 12. Interfering with chemokine networks--the hope for new therapeutics.
    Schwarz MK, Wells TN.
    Curr Opin Chem Biol; 1999 Aug; 3(4):407-17. PubMed ID: 10419853
    [Abstract] [Full Text] [Related]

  • 13. [Chemokine receptors: their role in human immunodeficiency virus (HIV) pathogenicity and resistance to HIV infections].
    Us D.
    Mikrobiyol Bul; 2003 Jan; 37(1):75-87. PubMed ID: 12838682
    [Abstract] [Full Text] [Related]

  • 14. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
    Kumar S, Choi WT, Dong CZ, Madani N, Tian S, Liu D, Wang Y, Pesavento J, Wang J, Fan X, Yuan J, Fritzsche WR, An J, Sodroski JG, Richman DD, Huang Z.
    Chem Biol; 2006 Jan; 13(1):69-79. PubMed ID: 16426973
    [Abstract] [Full Text] [Related]

  • 15. The chemokine family. Potential therapeutic targets from allergy to HIV infection.
    Proudfoot AE.
    Eur J Dermatol; 1998 Jan; 8(3):147-57. PubMed ID: 9649701
    [Abstract] [Full Text] [Related]

  • 16. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z, Schwarz M, Power CA, Wells TN, Proudfoot AE.
    Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240
    [Abstract] [Full Text] [Related]

  • 17. Roles of chemokines and chemokine receptors in HIV-1 infection.
    Murakami T, Yamamoto N.
    Int J Hematol; 2000 Dec; 72(4):412-7. PubMed ID: 11197206
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New therapeutics that modulate chemokine networks.
    Schwarz MK, Wells TN.
    Nat Rev Drug Discov; 2002 May; 1(5):347-58. PubMed ID: 12120410
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.